BioNexus Status is a special status awarded to qualified companies undertaking biotechnology activities. BioNexus Status companies are eligible for fiscal incentives, funding, and other guarantees to increase their growth, including investment facilitation and advisory services. Apart from the overall benefits and support, BioNexus Status companies are assured a list of privileges as stipulated in the BioNexus Status Bill of Guarantees.
BioNexus Status
Bill of Guarantees
Tax incentives
01
Income tax exemption on non-IP income (100% income tax exemption on statutory income):
For a period of ten (10) consecutive years of assessment commencing from the first (1st) year of assessment the company derives its statutory income from the new business
OR
For a period of five (5) consecutive years of assessment commencing from the first (1st) year of assessment the company derives its statutory income upon completion of its expansion project.
The tax exemption is on the statutory income from non-IP of the existing business and expansion project.
OR
02
Investment Tax Allowance (ITA) of 100% on qualifying capital expenditure (QCE) incurred within a period of five (5) years from the date the first (1st) QCE is incurred. This allowance can be off-set against a maximum of 70% of statutory income from a new business or expansion project.
AND
03
Concessionary tax rate of 20% on statutory income from non-IP of approved QA, for a period of ten (10) consecutive years of assessment upon the expiry of the income tax exemption.
04
Tax deduction equivalent to the total investment made at the initiation of commercialisation stage by a company or an individual (that carries out the business), for financing the activity in a BioNexus Status company.
05
Industrial Building Allowance (IBA) on qualifying expenditure used solely for the purpose of a new business or expansion project for a period of ten (10) years of assessment.
06
Exemption of import duty and sales tax on imported raw materials/components and machinery and equipment.
07
Double deduction on expenditure incurred for R&D.
08
Double deduction on expenditure incurred for the promotion of exports.
Eligibility Criteria
The following criteria must be met by a company wishing to apply for the BioNexus Status:
Proposed qualifying activity (products / services) must have biotechnology element and technology ready to be commercialised;
Proposed QA must be undertaken in Malaysia;
Undertakes continuous research & development (R&D) activity; and
Company incorporated in Malaysia with minimum paid-up capital of RM250,000 (for new and existing business)
How to Apply?
BioNexus Status companies can operate, anywhere in Malaysia with greater flexibility and agility with our flexible and agile incentives.